Table 3. Antibiotic resistance testing among selected microorganisms isolated in healthcare-associated pneumonia, ECDC point prevalence survey in acute care hospitals, European Union/European Economic Areaa, 2011–2012 (n = 841 isolates).
Selected pathogens and antimicrobial resistance | Total | Intubation-associated pneumonia | Time of onset | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n resistant or non-susceptible / N tested | % resistant or non-susceptible | Yes | No/Unknown | p value | ≤ 4 days | 5–7 days | ≥ 7 days | p value | ||||||
n resistant or non-susceptible / N tested | % resistant or non-susceptible | n resistant or non-susceptible / N tested | % resistant or non-susceptible | n resistant or non-susceptible / N tested | % resistant or non-susceptible | n resistant or non-susceptible / N tested | % resistant or non-susceptible | n resistant or non-susceptible / N tested | % resistant or non-susceptible | |||||
Antimicrobial-resistant Gram-positive coccib | 76 / 177 | 43 | 30 / 83 | 36 | 46 / 94 | 49 | NS | 4 / 31 | 13 | 12 / 27 | 44 | 43 / 81 | 53 | 0.007 |
Staphylococcus aureus, resistant to meticillin (MRSA) | 73 / 157 | 47 | 30 / 73 | 41 | 43 / 84 | 51 | NS | 4 / 30 | 13 | 12 / 23 | 52 | 40 / 71 | 56 | 0.004 |
Enterococcus spp., resistant to vancomycin | 3 /20 | 15 | 0 / 10 (0) | 0 | 3 / 10 | 30 | NS | 0 / 1 | 0 | 0 / 4 | 0 | 3 / 10 | 30 | NS |
Antimicrobial-resistant non-fermenting Gram-negative bacteriac | 172 / 316 | 54 | 128 / 219 | 58 | 44 / 97 | 45 | 0.04 | 7 / 27 | 26 | 16 / 34 | 47 | 113 / 191 | 59 | 0.01 |
Pseudomonas aeruginosa, non-susceptible to carbapenem | 81 / 204 | 40 | 53 / 132 | 40 | 28 / 72 | 39 | NS | 4 / 23 | 17 | 4 / 18 | 22 | 55 / 122 | 45 | 0.04 |
Acinetobacter spp., non-susceptible to carbapenems | 91 / 112 | 81 | 75 / 87 | 86 | 16 / 25 | 64 | 0.005 | 3 / 4 | 75 | 12 /16 | 75 | 58 / 69 | 84 | NS |
Enterobacteriaceae, non-susceptible to third-generation cephalosporins | 139 / 348 | 40 | 91 /224 | 41 | 48 / 124 | 39 | NS | 16 / 57 | 28 | 9 / 44 | 20 | 81 / 175 | 46 | 0.02 |
Enterobacteriaceae, non-susceptible to carbapenems | 38 / 336 | 11 | 25 / 214 | 12 | 13 / 122 | 11 | NS | 4 / 55 | 7 | 1 / 41 | 2 | 24 / 170 | 14 | NS |
Klebsiella spp., non-susceptible to carbapenems | 32 / 128 | 25 | 19 / 81 | 23 | 13 / 47 | 28 | NS | 2 / 25 | 8 | 0 / 11 | 0 | 23 / 64 | 0.003 | |
Escherichia coli, non-susceptible to carbapenems | 3 / 88 | 3 | 3 / 55 | 5 | 0 / 33 | 0 | NS | 1 / 11 | 9 | 0 / 14 | 0 | 1 / 44 | 2 | NS |
Total | 387 / 841 | 46 | 249 / 526 | 47 | 138 / 315 | 44 | NS | 27 / 115 | 23 | 37 / 105 | 35 | 237 / 447 | 53 | < 0.001 |
ECDC: European Centre for Disease Prevention and Control; NS: not statistically significant (p > 0.05); spp.: species.
aEuropean Union countries, plus Croatia (EU Member State since 1 July 2013), Iceland and Norway.
bLimited to meticillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus spp.
cLimited to carbapenem-non-susceptible Pseudomonas aeruginosa or carbapenem-non-susceptible Acinetobacter spp.